IRIS - Res&Arch Institutional Research Information System - Research & Archive

MORETTI, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.570
EU - Europa 1.321
AS - Asia 961
SA - Sud America 163
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.547
SG - Singapore 422
UA - Ucraina 277
SE - Svezia 195
IE - Irlanda 180
CN - Cina 158
BR - Brasile 145
HK - Hong Kong 145
FR - Francia 125
DE - Germania 122
IT - Italia 116
RU - Federazione Russa 104
VN - Vietnam 98
KR - Corea 88
FI - Finlandia 73
GB - Regno Unito 42
BE - Belgio 16
RO - Romania 13
AT - Austria 10
CH - Svizzera 10
MX - Messico 10
PL - Polonia 10
BD - Bangladesh 9
IN - India 9
CA - Canada 8
NL - Olanda 8
AR - Argentina 7
TR - Turchia 6
EU - Europa 5
CO - Colombia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
ID - Indonesia 4
BG - Bulgaria 3
EG - Egitto 3
ES - Italia 3
IQ - Iraq 3
LB - Libano 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
IL - Israele 2
JP - Giappone 2
KE - Kenya 2
PY - Paraguay 2
AM - Armenia 1
BZ - Belize 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 4.030
Salva come PNG Salva come JPEG
Città #
Chandler 276
Singapore 274
Dublin 180
Jacksonville 152
Hong Kong 145
San Mateo 100
Ashburn 76
Boardman 72
Ann Arbor 69
Seoul 69
Santa Clara 68
Dong Ket 66
Munich 56
Medford 52
Princeton 49
Altamura 43
Wilmington 43
Beijing 42
Moscow 34
Andover 33
Lawrence 31
Perugia 29
Piscataway 23
Redmond 19
Turku 19
Los Angeles 17
Brussels 16
Woodbridge 16
New York 15
Auburn Hills 13
São Paulo 13
Bucharest 12
Ho Chi Minh City 12
Falls Church 10
Hanoi 9
Shanghai 9
Helsinki 8
Saint Petersburg 8
Chicago 7
London 7
Norwalk 7
Dallas 6
Redwood City 6
Warsaw 6
Atlanta 5
Brooklyn 5
Falkenstein 5
Nuremberg 5
Rio de Janeiro 5
Stockholm 5
Brasília 4
Charlotte 4
Chennai 4
Columbus 4
Curitiba 4
Den Haag 4
Guangzhou 4
Izmir 4
Lausanne 4
Orem 4
San Jose 4
San Paolo di Civitate 4
Toronto 4
Belo Horizonte 3
Denver 3
Des Moines 3
Manaus 3
Manchester 3
Montreal 3
Phoenix 3
Piracicaba 3
Ribeirão Preto 3
Rome 3
Vienna 3
Ajman 2
Amsterdam 2
Arraial do Cabo 2
Assisi 2
Bogotá 2
Boston 2
Cajamar 2
Campo Largo 2
Cleveland 2
Council Bluffs 2
Damietta 2
Edinburgh 2
Florianópolis 2
Fremont 2
Fuzhou 2
Goiânia 2
Ivrea 2
Limeira 2
Medellín 2
Mountain View 2
Norfolk 2
Philadelphia 2
Querétaro 2
Raleigh 2
Recife 2
San Francisco 2
Totale 2.384
Salva come PNG Salva come JPEG
Nome #
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 131
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 129
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 129
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 114
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 113
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 110
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 108
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 108
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 103
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 100
Medicina molecolare in chirurgia della tiroide 99
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 98
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 98
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 97
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 97
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 93
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 93
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 90
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 89
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 88
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 87
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 85
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 84
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 82
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 81
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 81
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 76
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 76
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 76
Oncogeni e chirurgia della tiroide 70
Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum 69
Search of RET/PTC rearrangement and BRAF and RAS mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of BRAF mutation and allowed to detect a new mutation of BRAF oncoprotein 68
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 68
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 68
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 68
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway 68
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 67
Clinical prognosis in BRAF-mutated PTC 66
Sunitinib inhibits the growth of thyroid tumor xenografts in mice by acting primarily on tumor angiogenesis 65
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. 64
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells 63
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. 63
EFFETTO DI DUE INIBITORI CHINASICI IN LINEE CELLULARI DI CARCINOMA TIROIDEO: STUDI IN VITRO E IN VIVO 61
Targeted molecular therapies in thyroid carcinoma. 60
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response 57
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 54
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation 52
L’INIBIZIONE DI IDO1 (INDOLEAMMINA 2,3-DIOSSIGENASI 1) RIDUCE LA PROLIFERAZIONE DELLE CELLULE FTC133 47
Inactivating D594V and G596R amino acid substitutions have a dominant inhibitory effect on the V600E activating mutation of BRAF. 43
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer 38
Classification of thyroid diseases using machine learning and Bayesian graph algorithms 36
Totale 4.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 41 43 14 62 22 51 76
2021/2022446 16 74 10 43 9 3 7 145 2 23 44 70
2022/2023740 61 147 7 77 62 68 0 40 246 1 26 5
2023/2024267 24 32 9 5 3 2 43 18 49 7 46 29
2024/2025742 15 67 68 20 73 33 6 64 140 40 146 70
2025/2026758 110 116 68 168 188 108 0 0 0 0 0 0
Totale 4.130